LEADER 01904nam  2200553Ia 450 
001 9910780010703321
005 20230919173356.0
010   $a1-280-22176-3
010   $a9786610221769
010   $a0-309-56820-X
035   $a(CKB)111069351106016
035   $a(OCoLC)726823260
035   $a(CaPaEBR)ebrary10071469
035   $a(SSID)ssj0000210891
035   $a(PQKBManifestationID)12056718
035   $a(PQKBTitleCode)TC0000210891
035   $a(PQKBWorkID)10292349
035   $a(PQKB)11568247
035   $a(MiAaPQ)EBC3377441
035   $a(Au-PeEL)EBL3377441
035   $a(CaPaEBR)ebr10071469
035   $a(OCoLC)923270546
035   $a(EXLCZ)99111069351106016
100   $a19861211g1986      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDiseases of importance in developing countries $eestablishing priorities /$fby the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
210  1$aWashington, D.C. :$cNational Academy Press,$d1986.
215   $a1 online resource  (xvi, 432 pages)
225 0 $aNew vaccine development ;$vv.2
300   $aPrepared for the National Institute of Allergy and Infectious Diseases.
311 0 $a0-309-03679-8 
320   $aIncludes bibliographies and indexes.
606   $aVaccination$zDeveloping countries
606   $aVaccination$zUnited States
606   $aVaccines$xResearch$xGovernment policy
615  0$aVaccination
615  0$aVaccination
615  0$aVaccines$xResearch$xGovernment policy.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910780010703321
996   $aDiseases of importance in developing countries$93768221
997   $aUNINA